Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease ovarian cancer
Symptom C0027947|neutropenia
Sentences 3
PubMedID- 24657302 Cost-effectiveness of prophylaxis treatment strategies for febrile neutropenia in patients with recurrent ovarian cancer.
PubMedID- 24761216 Clinical trials have reported that the incidence of febrile neutropenia in patients with ovarian cancer receiving paclitaxel and carboplatin (tc) chemotherapy is<10% , and the guidelines indicate that csfs are not needed for primary prophylaxis in these patients.
PubMedID- 26267078 13 reported febrile neutropenia in 7% of patients with ovarian cancer during primary chemotherapy.

Page: 1